Effectiveness of 16% Carbamide Peroxide in Reducing Hypersensitivity During Alternate-day Home Bleaching
Efficacy in the Reduction of Hypersensitivity During Home Whitening With 16% Carbamide Peroxide Applied on Alternate Days: a Randomized Clinical Trial
1 other identifier
interventional
110
1 country
1
Brief Summary
The concentration of 16% carbamide peroxide is the highest concentration that European regulations allow for use in home whitening (Council directive 2011/84/EU). This concentration allows for faster results, but instead patients may suffer more frequently from dental sensitivity. The most commonly described side effect of all whitening procedures is the appearance of dentin hypersensitivity, hence the efforts to counteract or overcome this adverse effect. The objective of the study is to clinically evaluate the difference in dental hypersensitivity produced by home dental whitening treatment using 16% carbamide peroxide in a tray for two hours daily applied daily or every other day for three weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 6, 2023
CompletedFirst Posted
Study publicly available on registry
September 13, 2023
CompletedStudy Start
First participant enrolled
January 6, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 27, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedOctober 2, 2025
September 1, 2025
1.1 years
September 6, 2023
September 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Dental Sensitivity Visual Analog Scale (VAS) 0-10
The aim of this study is to clinically evaluate the incidence of tooth sensitivity induced by home whitening with 16% carbamide peroxide applied in a tray for two hours daily or every other day for three weeks. For the assessment, the operators will apply air to the cervical area of the upper and lower canines and ask the patient if he/she experienced sensitivity at any time during the treatment.
3 weeks
Secondary Outcomes (1)
Whitening Efficacy CIEL*a*b*
1 month
Other Outcomes (2)
Gingival irritation VAS (0-10)
3 weeks
Patient's oral quality of life (OHIP-14)
1 month
Study Arms (2)
Daily whitening
ACTIVE COMPARATORVolunteers should whiten daily with a whitening tray from 15 to 25 and 35 to 45 for 2 hours. This procedure will last 3 weeks.
Alternate whitening
EXPERIMENTALVolunteers will bleach for 3 weeks with 16% carbamide peroxide, alternating one rest day for each placement day. They will wear a whitening tray from 15 to 25 and from 35 to 45 for 2 hours.
Interventions
Daily application of a 16% carbamide peroxide bleaching gel in volunteers without sensitivity.
Volunteers will apply the whitening gel at 16% carbamide peroxide, alternating a rest day with an application day. Patients should not be sensitive before starting the study.
Eligibility Criteria
You may qualify if:
- Patients older than 18 years.
- Patients with vital teeth without restorations, single crowns, implants and/or bridges at the level of the anterior teeth.
- Absence of cavities in the teeth to be whitened.
- Patients with satisfactory oral hygiene and periodontally healthy, who are not undergoing periodontal maintenance and who do not use chlorhexidine mouthwashes. Patients with recessions without presenting sensitivity will be included.
- Absence of sensitivity, measured with the application of air with the dental team's syringe.
- Patients whose canines have at least an A2-A3 shade (VITA Classic® Guide).
You may not qualify if:
- Patients who have previously undergone whitening (less than 5 years).
- Patients undergoing orthodontic treatment.
- Patients with white spots or alterations in the development of enamel or with stains.
- Patients with a history of trauma to anterior teeth.
- Patients who require internal whitening.
- Smokers.
- Pregnant or lactating.
- Patients with allergies to any whitening component.
- Patients presenting alterations of the oral mucosa (desquamative gingivitis, oral lichen planus, leukoplakia, etc.).
- Patients with medical conditions considered by the researchers that may compromise the study or the individual safety of the patient.
- Patients with poor oral hygiene.
- Patients with previous hypersensitivity.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Isabel Giraldez de Luis
Alcorcón, Madrid, 28922, Spain
Related Publications (3)
Cardoso PC, Reis A, Loguercio A, Vieira LC, Baratieri LN. Clinical effectiveness and tooth sensitivity associated with different bleaching times for a 10 percent carbamide peroxide gel. J Am Dent Assoc. 2010 Oct;141(10):1213-20. doi: 10.14219/jada.archive.2010.0048.
PMID: 20884923BACKGROUNDChagas AS, Freitas KMS, Cancado RH, Valarelli FP, Canuto LFG, Oliveira RCG, Oliveira RCG. Level of satisfaction in the use of the wraparound Hawley and thermoplastic maxillary retainers. Angle Orthod. 2020 Jan;90(1):63-68. doi: 10.2319/031319-197.1. Epub 2019 Jul 22.
PMID: 31335161BACKGROUNDde Geus JL, Wambier LM, Boing TF, Loguercio AD, Reis A. At-home Bleaching With 10% vs More Concentrated Carbamide Peroxide Gels: A Systematic Review and Meta-analysis. Oper Dent. 2018 Jul/Aug;43(4):E210-E222. doi: 10.2341/17-222-L.
PMID: 29949477BACKGROUND
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The present study presents blinding of both the evaluator and the person who will carry out the statistical analysis, and therefore double-blind. The evaluators are considered blind in this study because they do not know the randomization of the patients, being a blind study. The operator and patients know the groups in which they are assigned, due to the delivery and placement of the splints. A block randomization of the treatment applied to the patients will be carried out, to ensure that the sample size is similar in both groups. The operator will open an envelope for the group's allocation. The assignment of the groups will be carried out using opaque, sealed and sequentially numbered envelopes. The operator will open the envelope when the splints are delivered, and will give the pertinent explanations to the patient. Data will be collected from each patient that may influence treatment results such as age, sex, initial color, systemic pathologies and pharmacological treatments.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Department for Conservative Dentistry at Rey Juan Carlos University
Study Record Dates
First Submitted
September 6, 2023
First Posted
September 13, 2023
Study Start
January 6, 2024
Primary Completion
February 27, 2025
Study Completion
September 1, 2025
Last Updated
October 2, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share
The results obtained will only be shared once they have been published in an impact journal.